For over 15 years, MSFHR, Praxis Spinal Cord Institute and ICORD have partnered to support health researchers in BC who have collectively revolutionized the field of spinal cord research.
The 2020 Innovation to Commercialization and Health Professional-Investigator awardees are applying research and innovations to improve health outcomes for British Columbians.
By investing in and supporting health research, we are continuing to support British Columbians through the pandemic and our province’s economic recovery.
Dr. Brian Kwon and his research team are using MSFHR funding to advance a novel technology to improve outcomes for patients with spinal cord injury.
MSFHR and Mitacs have partnered to support joint applications so researchers can access both Mitacs and MSFHR funding with one application.
Nine BC health researchers have been funded in MSFHR’s third Innovation to Commercialization (I2C) competition. Continue reading “MSFHR funds nine BC health researchers moving innovations towards practical application”
2003 Scholar and 2017 I2C award recipient Dr. David Granville has identified an enzyme potentially responsible for skin blistering, and is developing an inhibitor to prevent and treat the condition.
Eight BC health researchers have been funded in MSFHR’s second Innovation to Commercialization competition.
Christopher Ong says his 2017 I2C award came at an opportune time in the development of a new drug that could stop prostate cancer in its tracks.